Two inotropic agents: dopamine and dobutamine
Cleary, J.D.
Pediatric Nursing 14(5): 414
1988
ISSN/ISBN: 0097-9805 PMID: 3186313 Document Number: 309474
Document emailed within 1 workday
Related Documents
Huss, P.; Miller, J.; Unverferth, D.V.; Leier, C.V. 1981: The new inotropic drug, dobutamine Heart and Lung: the Journal of Critical Care 10(1): 121-126Ismail-Zade, I.A.; Trifonova, N.A.; Stepanenko, S.M. 1994: Use of the current cardiac inotropic agent dobutamine in pediatric surgical clinics Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 3: 31-34
Heinen, E.; Herrmann, J.; Lippe, J.; Dudek, M.; Krüskemper, H.L. 1983: Effect of dopamine and dobutamine on thyroid hormone concentration Die Medizinische Welt 34(24): 696-699
Good, J.; Frost, G.; Oakley, C.M.; Cleland, J.G. 1992: The renal effects of dopamine and dobutamine in stable chronic heart failure Postgraduate Medical Journal 68(Suppl 2): S7-11
Cun, Y.; Jianlong, W. 2020: Application of dopamine combined with dobutamine in children with pneumonia and heart failure Pakistan Journal of Pharmaceutical Sciences 33(3(Special): 1355-1359
Kosugi, I.; Nagai, H.; Okada, K.; Matsushima, K. 1979: Effect of dopamine and dobutamine on arterial oxygen tension and pulmonary shunt Masui. Japanese Journal of Anesthesiology 28(5): 477-482
Tarr, T.J.; Moore, N.A.; Frazer, R.S.; Shearer, E.S.; Desmond, M.J. 1993: Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery European Journal of Anaesthesiology. Supplement 8: 15-24
Seres, T.; Fehér, G.; Takács, E.I. 1990: Inotropic response of "stunned" myocardium induced by dopamine in dogs Acta Physiologica Hungarica 75(Suppl): 257-258
Watanabe, N.; Kazui, T.; Matsuzaki, T.; Tanaka, T.; Yamada, O.; Sasaki, T.; Komatsu, S. 1985: Hemodynamic effects of combination treatment with dopamine and dobutamine in patients following open heart surgery Nihon Kyobu Geka Gakkai 33(7): 1051-1059
Matsumura, S.; Morishige, E.; Uno, O.; Ueda, M. 1980: Comparative studies on the hemodynamic effects of dobutamine, dopamine, and isoproterenol in dogs in experimental shock Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(2): 131-141
Tatsuta, N.; Murata, S.; Kao, C.; Matsuda, K.; Chiba, Y.; Murata, K.; Taniguchi, T.; Shiraishi, Y.; Matsuda, M.; Konishi, Y.; Miki, S.; Hikasa, Y. 1979: Circulatory effects of dobutamine and dopamine in dogs following experimental injury of the sino-atrial node Nihon Geka Hokan. Archiv für Japanische Chirurgie 48(5): 587-601
Sardesai, S.; Durand, M.; McEvoy, C.; Johnson, C.; Maarek, J.M. 1996: Pulse oximetry in newborn infants with birth weights of 620 to 4285 grams receiving dopamine and dobutamine Journal of Perinatology: Official Journal of the California Perinatal Association 16(1): 31-34
Husedzinović, I.; Rumboldt, Z.; Ivancan, V.; Nikić, N.; Rudeź, I.; Biocina, B.; Sutlić, Z. 1995: Hemodynamic effects of amrinone, dobutamine and dopamine in the cardiac low output syndrome following open-heart surgery Lijecnicki Vjesnik 117(Suppl 2): 32-34
Ishihata, A.; Kushida, H.; Endoh, M. 1988: Enantiomers of dobutamine increase the force of contraction via beta adrenoceptors, but antagonize competitively the positive inotropic effect mediated by alpha-1 adrenoceptors in the rabbit ventricular myocardium Journal of Pharmacology and Experimental Therapeutics 246(3): 1080-1087
Sasayama, S. 2003: Inotropic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 61(5): 807-814
Lee, R.D.; Choe, E.; Flint, L.; Steinberg, S. 1998: Neither dopamine nor dobutamine corrects mesenteric blood flow depression caused by positive end-expiratory pressure in a rat model of acute lung injury Critical Care Medicine 26(11): 1875-1880
Asanoi, H. 2003: Positive inotropic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 61(5): 827-832
Sharpe, D.N. 1984: Newer inotropic agents Methods and Findings in Experimental and Clinical Pharmacology 6(4): 215-218
Méndez, R. 1983: The old digitalis and the new cardiac inotropic agents Archivos de Farmacologia y Toxicologia 9(1): 4-20
Spilker, B.A. 1973: A comparative description of inotropic agents in vitro Archives Internationales de Pharmacodynamie et de Therapie 202(2): 325-341